Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015

被引：0
|
作者：
Suvanna Asavapiriyanont
Wanitchaya Kittikraisak
Piyarat Suntarattiwong
Darunee Ditsungnoen
Surasak Kaoiean
Podjanee Phadungkiatwatana
Nattinee Srisantiroj
Tawee Chotpitayasunondh
Fatimah S. Dawood
Kim A. Lindblade
机构：
[1] Rajavithi Hospital,Influenza Division
[2] Influenza Program,undefined
[3] Thailand Ministry of Public Health – U.S. Centers for Disease Control and Prevention Collaboration,undefined
[4] Queen Sirikit National Institute of Child Health,undefined
[5] U.S. Centers for Disease Control and Prevention,undefined
来源：
BMC Pregnancy and Childbirth | / 18卷
关键词：
Tolerability; Influenza; Vaccination; Pregnant women; Thailand;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico
    Ruiz-Palacios, Guillermo M.
    Beigel, John H.
    Guerrero, Maria Lourdes
    Bellier, Lucile
    Tamayo, Ramiro
    Cervantes, Patricia
    Alvarez, Fabian P.
    Galindo-Fraga, Arturo
    Aguilar-Ituarte, Felipe
    Guillermo Lopez, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 827 - 835
  • [32] Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
    Kotecha, Rishi S.
    Wadia, Ushma D.
    Jacoby, Peter
    Ryan, Anne L.
    Blyth, Christopher C.
    Keil, Anthony D.
    Gottardo, Nicholas G.
    Cole, Catherine H.
    Barr, Ian G.
    Richmond, Peter C.
    CANCER MEDICINE, 2016, 5 (02): : 285 - 293
  • [33] Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
    Halasa, Natasha B.
    Savani, Bipin N.
    Asokan, Ishan
    Kassim, Adetola
    Simons, Rhea
    Summers, Chelsey
    Bourgeois, John
    Clifton, Carey
    Vaughan, Leigh Ann
    Lucid, Catherine
    Wang, Li
    Fonnesbeck, Christopher
    Jagasia, Madan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 528 - 535
  • [34] Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
    Spencer, Sarah
    Chung, Jessie R.
    Belongia, Edward A.
    Sundaram, Maria
    Meece, Jennifer
    Coleman, Laura A.
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Geffel, Krissy Moehling
    Ross, Ted
    Carter, Chalise E.
    Shay, David
    Levine, Min
    Liepkalns, Justine
    Kim, Jin Hyang
    Sambhara, Suryaprakash
    Thompson, Mark G.
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (03) : 562 - 567
  • [35] The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
    Van Buynder, P. G.
    Konrad, S.
    Van Buynder, J. L.
    Brodkin, E.
    Krajden, M.
    Ramler, G.
    Bigham, M.
    VACCINE, 2013, 31 (51) : 6122 - 6128
  • [36] Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma
    Fleming, Douglas M.
    Crovari, Pietro
    Wahn, Ulrich
    Klemola, Timo
    Schlesinger, Yechiel
    Langussis, Alexangros
    Oymar, Knut
    Garcia, Maria Luz
    Krygier, Alain
    Costa, Herculano
    Heininger, Ulrich
    Pregaldien, Jean-Louis
    Cheng, Sheau-Mei
    Skinner, Jonathan
    Razmpour, Ahmad
    Saville, Melanie
    Gruber, William C.
    Forrest, Bruce
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) : 860 - 869
  • [37] Influenza 2014–2015 among pregnant Japanese women: primiparous vs multiparous women
    T. Yamada
    S. Kawakami
    Y. Yoshida
    H. Kawamura
    S. Ohta
    K. Abe
    H. Hamada
    S. Dohi
    K. Ichizuka
    H. Takita
    Y. Baba
    S. Matsubara
    J. Mochizuki
    N. Unno
    Y. Maegawa
    M. Maeda
    E. Inubashiri
    N. Akutagawa
    T. Kubo
    T. Shirota
    Y. Oda
    T. Yamada
    E. Yamagishi
    A. Nakai
    N. Fuchi
    H. Masuzaki
    S. Urabe
    Y. Kudo
    M. Nomizo
    N. Sagawa
    T. Maeda
    M. Kamitomo
    K. Kawabata
    S. Kataoka
    A. Shiozaki
    S. Saito
    A. Sekizawa
    H. Minakami
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 665 - 671
  • [38] Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Simon, Jakub K.
    Carter, Mihaela
    Pasetti, Marcela F.
    Sztein, Marcelo B.
    Kotloff, Karen L.
    Weniger, Bruce G.
    Campbell, James D.
    Levine, Myron M.
    VACCINE, 2011, 29 (51) : 9544 - 9550
  • [39] Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial
    Vesikari, Timo
    Virta, Miia
    Heinonen, Seppo
    Eymine, Cecile
    Lavis, Nathalie
    Chabanon, Anne Laure
    Gresset-Bourgeois, Viviane
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 623 - 629
  • [40] Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010
    Choe, Young June
    Cho, Heeyeon
    Kim, Sung Nam
    Bae, Geun-Ryang
    Lee, Jong-Koo
    VACCINE, 2011, 29 (44) : 7727 - 7732
12345